These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7587199)

  • 1. Use of cyclosporin in lupus nephritis.
    Radhakrishnan J; Valeri A; Kunis C; Appel GB
    Contrib Nephrol; 1995; 114():59-72. PubMed ID: 7587199
    [No Abstract]   [Full Text] [Related]  

  • 2. Remission from lupus nephritis resistant to cyclophosphamide after additional treatment with cyclosporin A.
    Ferrario L; Bellone M; Bozzolo E; Baldissera E; Sabbadini MG
    Rheumatology (Oxford); 2000 Feb; 39(2):218-220. PubMed ID: 10725082
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine (CsA) in lupus nephritis: assessing the evidence.
    Moroni G; Doria A; Ponticelli C
    Nephrol Dial Transplant; 2009 Jan; 24(1):15-20. PubMed ID: 18852191
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of steroid-resistant membranous lupus nephritis with plasmapheresis and low-dose cyclosporine.
    Fujinaga S; Ohtomo Y; Umino D; Mochizuki H; Takemoto M; Shimizu T; Yamashiro Y; Kaneko K
    Pediatr Nephrol; 2007 Apr; 22(4):616-7. PubMed ID: 17115192
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycophenolate mofetil therapy for children with lupus nephritis refractory to both intravenous cyclosphosphamide and cyclosporine.
    Fu YF; Liu GL
    Clin Nephrol; 2001 Apr; 55(4):318-21. PubMed ID: 11334319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciclosporin A in lupus nephritis.
    Erdem Y; Yalçin AU; Oymak O; Yasavul U; Turgan C; Cağlar S
    Nephron; 1996; 72(2):332. PubMed ID: 8684556
    [No Abstract]   [Full Text] [Related]  

  • 7. [Response to mycophenolate mofetil in a case of lupus nephropathy resistant to cyclophosphamide IV and cyclosporin A].
    Navas-Parejo A; Espigares MJ; Alhosni A; García-Valdecasas J
    Nefrologia; 2001; 21(5):516-7. PubMed ID: 11795027
    [No Abstract]   [Full Text] [Related]  

  • 8. Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy.
    Mao Y; Yin L; Huang H; Zhou Z; Chen T; Zhou W
    J Int Med Res; 2019 Jan; 47(1):105-113. PubMed ID: 30208769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral lupus in patients whilst on treatment for lupus nephritis with cyclosporine.
    Hussein M; Mooij J; Roujouleh H
    J Clin Neurosci; 2003 Jan; 10(1):104-6. PubMed ID: 12464536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis.
    Sheikholeslami M; Hajialilo M; Rasi Hashemi SS; Malek Mahdavi A; Gojazadeh M; Khabbazi A
    Mod Rheumatol; 2018 May; 28(3):523-529. PubMed ID: 28753077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voclosporin: First Approval.
    Heo YA
    Drugs; 2021 Apr; 81(5):605-610. PubMed ID: 33788181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
    Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
    Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of renal transplantation under cyclosporine immunosuppression in patients with lupus nephritis.
    Cobankiat J; Vathsala A; Lu YM; Woo KT
    Transplant Proc; 2000 Nov; 32(7):1826-7. PubMed ID: 11119955
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment with cyclosporine A improves SLE disease activity of Japanese patients with diffuse proliferative lupus nephritis.
    Kamijo Y; Hashimoto K; Takahashi K; Ehara T; Shigematsu H; Higuchi M
    Clin Nephrol; 2011 Aug; 76(2):136-43. PubMed ID: 21762646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late recurrence of lupus nephritis in a renal transplant recipient: response to mycophenolate mofetil.
    Ahuja TS; Boughton J; Weiss V; Memon A; Remmers A; Rajaraman S
    Am J Med Sci; 2001 Sep; 322(3):166-9. PubMed ID: 11570784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of lupus nephritis with cyclosporin A.
    Tam LS; Li EK; Leung CB; Wong KC; Lai FM; Wang A; Szeto CC; Lui SF
    QJM; 1998 Aug; 91(8):573-80. PubMed ID: 9893761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recurrent lupus nephritis in kidney transplantation].
    Latorre LC; Saldanha LB; Bastos ME; Zerbini CA
    Rev Paul Med; 1989; 107(3):186-8. PubMed ID: 2699535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of lupus nephritis with cyclosporine - an outcome analysis.
    Rihova Z; Vankova Z; Maixnerova D; Dostal C; Jancova E; Honsova E; Merta M; Rysava R; Tesar V
    Kidney Blood Press Res; 2007; 30(2):124-8. PubMed ID: 17396037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide.
    Kurasawa T; Nagasawa H; Nishi E; Takei H; Okuyama A; Kondo T; Nishimura K; Sakai R; Shibata A; Chino K; Ogawa H; Ito T; Amano K; Kato H
    Intern Med; 2013; 52(10):1125-30. PubMed ID: 23676603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of measuring serum soluble IL-2 receptor levels in cyclosporine-A treated lupus nephritis].
    Zheng X; Lin M; Cui X; Yao Q; Zhou G; Guo Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Sep; 26(3):338-41. PubMed ID: 8586406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.